147 related articles for article (PubMed ID: 8951966)
1. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
[TBL] [Abstract][Full Text] [Related]
2. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
3. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
Chapman AG; Smith SE; Meldrum BS
Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
5. Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.
Gordon R; Gels M; Diamantis W; Sofia RD
Pharmacol Biochem Behav; 1991 Sep; 40(1):109-13. PubMed ID: 1664105
[TBL] [Abstract][Full Text] [Related]
6. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.
De Sarro G; Renne S; Nava F; De Sarro A
J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713
[TBL] [Abstract][Full Text] [Related]
7. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
Domenici MR; Marinelli S; Sagratella S
Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
[TBL] [Abstract][Full Text] [Related]
8. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
De Sarro G; Ammendola D; Nava F; De Sarro A
Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525
[TBL] [Abstract][Full Text] [Related]
9. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
Neuropharmacology; 1993 Sep; 32(9):895-900. PubMed ID: 7694171
[TBL] [Abstract][Full Text] [Related]
10. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
[TBL] [Abstract][Full Text] [Related]
11. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
Chapman AG; al-Zubaidy Z; Meldrum BS
Eur J Pharmacol; 1993 Feb; 231(2):301-3. PubMed ID: 8453982
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.
Tomczyk T; Haberek G; Zuchora B; Jarosławska-Zych A; Kowalczyk MS; Wielosz M; Urbańska EM
Pharmacol Rep; 2007; 59(4):462-6. PubMed ID: 17901576
[TBL] [Abstract][Full Text] [Related]
13. Excitoprotective effect of felbamate in cultured cortical neurons.
Kanthasamy AG; Matsumoto RR; Gunasekar PG; Trunong DD
Brain Res; 1995 Dec; 705(1-2):97-104. PubMed ID: 8821739
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
15. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
16. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice.
Gasior M; Swiader M; Przybyłko M; Borowicz K; Turski WA; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1998 Jul; 352(2-3):207-14. PubMed ID: 9716356
[TBL] [Abstract][Full Text] [Related]
17. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
Swiader M; Gasior M; Wielosz M; Czuczwar SJ
Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
[TBL] [Abstract][Full Text] [Related]
18. Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist.
Domenici MR; Sagratella S; Ongini E; Longo R; Scotti de Carolis A
Eur J Pharmacol; 1994 Dec; 271(2-3):259-63. PubMed ID: 7705426
[TBL] [Abstract][Full Text] [Related]
19. NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.
De Sarro G; Siniscalchi A; Ferreri G; Gallelli L; De Sarro A
Eur J Pharmacol; 2000 Nov; 408(1):25-34. PubMed ID: 11070180
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
